Bernstein Sticks to Their Sell Rating for Bajaj Finance Limited (BAJFINANCE)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Dheeeraj Gundlapalle is a 3-star analyst with an average return of 9.2% and a 63.64% success rate.
In addition to Bernstein, Bajaj Finance Limited also received a Sell from UBS's Alok Srivastava in a report issued today. However, on the same day, Investec maintained a Hold rating on Bajaj Finance Limited (NSE: BAJFINANCE).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
4 hours ago
- Business Insider
U.S. Stock Futures Flat Despite New Highs for the S&P 500 and Nasdaq
U.S. stock futures opened flat on Monday night, even as the S&P 500 (SPX) and the Nasdaq Composite closed at a new high in the previous session. Futures on the Nasdaq 100 (NDX), the Dow Jones Industrial Average (DJIA), and the S&P 500 were up 0.19%, 0.06%, and 0.07%, respectively, at 11:07 p.m. EDT on July 28. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In Monday's trading session, the S&P 500 and the Nasdaq Composite hit new all-time intraday and closing highs, marking the S&P 500's 15 th record close of 2025. These gains were fueled by recent earnings results and international trade developments. Today, the S&P 500 ended just above flat, the Dow slipped 0.1%, and the Nasdaq rose 0.3%. Tariffs and inflation will remain key focus points this week. The Federal Reserve is scheduled to announce its interest rate decision on Wednesday, following its two-day policy meeting. The market anticipates that the central bank will keep rates steady in the 4.25% to 4.5% range. This week is also the busiest period of earnings season, with over 150 S&P 500 companies reporting quarterly results. This includes several 'Magnificent Seven' firms: Meta Platforms (META) and Microsoft (MSFT) on Wednesday, and Amazon (AMZN) and Apple (AAPL) on Thursday.
Business Insider
4 hours ago
- Business Insider
‘It's Only Just Begun,' Says Andres Sheppard About Tesla Stock
Tesla (NASDAQ:TSLA) stock is steering into the future – quite literally. On June 22, the company officially launched its much-anticipated robotaxi service in Austin. Tesla began using Model Y vehicles equipped with autonomous driving technology to transport select invite-only passengers around predefined neighborhoods at a playful flat fee of $4.20 per ride. For now, however, each vehicle still includes a safety monitor seated in the front passenger seat, providing an additional layer of supervision and reassurance during these autonomous trips. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. It wasn't long before Tesla took its next leap forward: on June 27, the company completed its first fully autonomous vehicle delivery. Imagine a Model Y quietly departing Tesla's Gigafactory, cruising effortlessly through Austin's streets, and parking itself in the customer's driveway without a single human intervention – that's exactly what happened. Furthermore, the company announced plans last week to ramp up its robotaxi operation in Austin by adding more vehicles and expanding service coverage. As the system matures and local regulations allow, Tesla aims to phase out the in-car safety monitors altogether, ushering in a truly driverless passenger experience. Looking further ahead, Tesla is already sketching out the next generation of autonomous ride-sharing. In 2026, the automaker plans to roll out its futuristic Cybercab – a purpose-built, fully autonomous vehicle without a steering wheel or pedals. Cantor analyst Andres Sheppard sees Tesla's latest moves as another powerful signal of the company's strategic edge in the rapidly evolving autonomous vehicle landscape. According to Sheppard, Tesla's focus on expanding its robotaxi services marks a critical step toward solidifying its role as a frontrunner in the competitive ride-sharing market. 'We expect Robotaxi expansion into the Bay Area (in 3Q), followed by Arizona, Nevada and possibly Florida (in 4Q25/2026E), subject to regulatory approvals… Overall, we continue to see Tesla's Robotaxi segment as a software-as-a-service, high-margin model, and we expect TSLA to have the ability to rapidly scale following commercialization. We expect TSLA will capture a leading market share in these industries,' Sheppard opined. To this end, Sheppard rates TSLA shares an Overweight (i.e., Buy) along with a $355 price target. (To watch Sheppard's track record, click here) What does the rest of the Street think? Looking at the consensus breakdown, opinions from other analysts are more spread out. 14 Buys, 15 Holds and 8 Sells add up to a Hold (i.e. Neutral) consensus rating. In addition, the $310.65 average price target indicates ~5% downside from current levels. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
4 hours ago
- Business Insider
What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?
UnitedHealth Group (UNH), the largest healthcare provider, is now one of the worst-hit stocks of 2025. Down 44% year-to-date, UNH stock was dragged down by rising costs in its Medicare Advantage business, a surprise CEO exit, and intensifying federal scrutiny into its billing practices. Currently, investors are looking for updates on the company's progress on the legal and financial front at the Q2 earnings, due July 29. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. What Went Wrong? The selloff in UNH stock began in April when UnitedHealth missed earnings and slashed its full-year guidance. This was followed by the resignation of CEO Andrew Witty in May. Also, last week, the company confirmed it is under both criminal and civil investigations by the Department of Justice. The probe centers on alleged overbilling in its Medicare Advantage program, specifically whether patient diagnoses were inflated to boost government reimbursements. Analysts Are Not That Bearish Despite the turmoil, Wall Street sentiment is mixed but not entirely bearish. Bernstein even named UNH a 'Top Pick,' citing its discounted valuation and long-term earnings potential. Further, the firm expects a doubling of EPS by 2029, driven by sector recovery and company-specific margin recovery. Others are more cautious. Wells Fargo and Truist Financial recently lowered their price targets, citing weak investor sentiment and concerns around Optum Health, UnitedHealth's services arm. All Eyes Are on UNH's Q2 Results Currently, analysts anticipate that Q2 earnings will fall to $4.48 from $6.80 a year ago. Meanwhile, revenue is expected to grow 12.8% to $111.50 billion. The bottom-line drop reflects higher-than-expected medical costs, especially in Medicare Advantage, which have hurt the company's margins. More than the Q2 numbers, investors are focused on CEO Stephen Hemsley offering a roadmap for recovery, including updated 2025 guidance and early signals for 2026. A full-year EPS outlook of below $18 could result in investors losing more confidence and trigger further selling. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, five Holds, and one Sell assigned in the last three months. At $348.12, the average UnitedHealth stock price target implies a 24.11% upside potential.
